NLRP3 and non-small cell lung carcinoma: The expression of NLRP3, Caspase‐1 and secretion of IL‐18 and IL‐1β were upregulated in EEBR‐treated NSCLC cells and tissues, and the EEBR‐activated NLRP3‐mediated inflammatory response was ameliorated by BAY pretreatment.